Newsroom

Sorted by: Latest

-

Nidec Announces Approval of an Extension of the Filing Deadline of Semi-Annual Securities Report for the 54th Fiscal Year (Ending March 31, 2027)

KYOTO, Japan--(BUSINESS WIRE)--As announced in " Notice Regarding Filing of an Application for Approval of an Extension of the Filing Deadline of Semi-Annual Securities Report for the 54th Fiscal Year (Ending March 31, 2027)" dated November 16, 2026, Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the "Company") had filed an application for approval of an extension of the filing deadline of Semi-Annual Securities Report for the 54th Fiscal Year (Ending March 31, 2027) prescribed in Article 18-2...
-

Deutsche Bank AG UK Regulatory Announcement: Buy-Back of Securities

LONDON--(BUSINESS WIRE)--  DB ETC plc COMPANY ANNOUNCEMENT Immediate Release 16 November 2026 Xtrackers Physical Gold ETC (EUR) (Incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Buy-Back of ETC Securities Announcement The Issuer has agreed to buy back the ETC Securities for the following Series as set out in the table below. Series Number of Securities to be bought back Trade Date Settlement Date ISIN Series 09 - Xtracke...
-

Deutsche Bank AG UK Regulatory Announcement: Issuance of Securities

LONDON--(BUSINESS WIRE)--  Dated: 16 November 2026 COMPANY ANNOUNCEMENT Immediate Release 16 November 2026 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 04 - Xtrackers Physical Silver EUR Hedged ETC 471 12,805 11 November 2026 13 Nov...
-

Deutsche Bank AG UK Regulatory Announcement: Value per Security

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 16 November 2026 COMPANY ANNOUNCEMENT Immediate Release 16 November 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 12 November 2026 Series ISIN Currency Value per Secur...
-

Riassunto: GigaDevice lancia la nuova generazione della gamma di MCU altamente performanti GD32H7 per applicazioni industriali a copertura totale

MONACO DI BAVIERA--(BUSINESS WIRE)--GigaDevice, una delle principali imprese nel settore dei dispositivi a semiconduttori, specializzata in memorie flash, microcontroller (MCU) a 32 bit, sensori e prodotti analogici, lancia ufficialmente la nuova generazione della gamma di MCU GD32H7, basata su un’architettura di chip unificata. Sviluppata a partire da un chip di silicio omologo con configurazione IP su misura, ottimizzazione dei dispositivi periferici e ottimizzazione per specifici scenari, la...
-

Samenvatting: GigaDevice lanceert de nieuwe generatie GD32H7-portfolio van hoogwaardige MCU’s voor industriële toepassingen in alle scenario’s

MÜNCHEN--(BUSINESS WIRE)--GigaDevice, een toonaangevend halfgeleiderbedrijf dat is gespecialiseerd in flashgeheugens, 32-bits microcontrollers (MCU’s), sensoren en analoge producten, lanceert officieel zijn nieuwe generatie GD32H7 MCU-portfolio, gebaseerd op een uniforme chiparchitectuur. Deze uitgebreide productreeks is ontwikkeld vanuit een homologe siliciumchip met een op maat gemaakte IP-configuratie, geoptimaliseerde randapparatuur en scenario-specifieke afstemming. De reeks is speciaal on...
-

Resumen: GigaDevice lanza la gama de microcontroladores de alto rendimiento GD32H7 de nueva generación para aplicaciones industriales en todo tipo de entornos

MÚNICH--(BUSINESS WIRE)--GigaDevice, una empresa líder en semiconductores especializada en memorias Flash, microcontroladores (MCU) de 32 bits, sensores y productos analógicos , lanza oficialmente su gama de microcontroladores GD32H7 de nueva generación, basada en una arquitectura de chip unificada. Desarrollada a partir de un chip de silicio homólogo con una configuración de propiedad intelectual (IP) a medida, optimización de los periféricos y ajuste específico para cada escenario, esta compl...
-

GigaDevice lance la gamme GD32H7 de microcontrôleurs haute performance de nouvelle génération, destinée à à un large éventail d'applications industrielles

MUNICH--(BUSINESS WIRE)--GigaDevice, une entreprise de premier plan dans le secteur des semi-conducteurs, spécialisée dans les mémoires Flash, les microcontrôleurs 32 bits (MCU), les capteurs et les produits analogiques , lance officiellement sa gamme de microcontrôleurs GD32H7 de nouvelle génération, reposant sur une architecture de puce unifiée. Développée à partir d’une même puce en silicium, avec une configuration IP personnalisée, une optimisation des périphériques et un réglage adapté à c...
-

GigaDevice bringt das GD32H7-Portfolio der neuen Generation mit Hochleistungs-MCUs für industrielle Anwendungen in allen Anwendungsbereichen auf den Markt

MÜNCHEN--(BUSINESS WIRE)--GigaDevice, ein führendes Halbleiterunternehmen, das sich auf Flash-Speicher, 32-Bit-Mikrocontroller (MCUs), Sensoren und analoge Produkte spezialisiert hat, bringt offiziell sein GD32H7-MCU-Portfolio der neuen Generation auf den Markt, das auf einer einheitlichen Chiparchitektur basiert. Die umfassende Produktpalette wurde auf Basis eines einheitlichen Silizium-Chips mit maßgeschneiderter IP-Konfiguration, optimierten Peripheriegeräten und szenariospezifischer Feinabs...
-

Laverock Therapeutics Appoints Parker Moss as Chief Executive Officer and Paul J. Sekhri as Executive Chairman

LONDON--(BUSINESS WIRE)--Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its programmable gene control technology, today announced the appointment of Parker Moss as Chief Executive Officer and member of the Board of Directors, and Paul J. Sekhri as Executive Chairman. Together they will lead Laverock through its transition into a clinical-stage company, including a Series A financing planned for 2027. Parker Moss is a life sci...